The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging

被引:1
|
作者
Chow, Ji-Jian [1 ]
Leong, Kevin M. W. [1 ]
Shun-Shin, Matthew [1 ]
Jones, Sian [2 ]
Guttmann, Oliver P. [3 ]
Mohiddin, Saidi A. [3 ,4 ]
Lambiase, Pier [3 ]
Elliott, Perry M. [3 ]
Ormerod, Julian O. M. [5 ]
Koa-Wing, Michael [1 ]
Lefroy, David [2 ]
Lim, Phang Boon [1 ]
Linton, Nicholas W. F. [1 ]
Ng, Fu Siong [1 ]
Qureshi, Norman A. [2 ]
Whinnett, Zachary I. [1 ]
Peters, Nicholas S. [1 ]
Francis, Darrel P. [1 ]
Varnava, Amanda M. [1 ]
Kanagaratnam, Prapa [1 ]
机构
[1] Imperial Coll, Natl Heart & Lung Inst, London, England
[2] Imperial Coll Healthcare NHS Trust, Cardiol Dept, London, England
[3] Barts Heart Ctr, Cardiol Dept, London, England
[4] Queen Mary Univ London, Cardiol Dept, London, England
[5] Oxford Univ Hosp NHS Trust, Cardiol Dept, Oxford, England
关键词
hypertrophic cardiomyopathy; sudden death; electrocardiographic imaging; implantable defibrillator; risk stratification; SUDDEN CARDIAC DEATH; ACTION-POTENTIAL DURATIONS; EUROPEAN-SOCIETY; CARDIOLOGY; FRACTIONATION; COLLEGE; MODEL;
D O I
10.3389/fphys.2024.1428709
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Patients with hypertrophic cardiomyopathy (HCM) are at risk for lethal ventricular arrhythmia, but the electrophysiological substrate behind this is not well-understood. We used non-invasive electrocardiographic imaging to characterize patients with HCM, including cardiac arrest survivors. Methods: HCM patients surviving ventricular fibrillation or hemodynamically unstable ventricular tachycardia (n = 17) were compared to HCM patients without a personal history of potentially lethal arrhythmia (n = 20) and a pooled control group with structurally normal hearts. Subjects underwent exercise testing by non-invasive electrocardiographic imaging to estimate epicardial electrophysiology. Results: Visual inspection of reconstructed epicardial HCM maps revealed isolated patches of late activation time (AT), prolonged activation-recovery intervals (ARIs), as well as reversal of apico-basal trends in T-wave inversion and ARI compared to controls (p < 0.005 for all). AT and ARI were compared between groups. The pooled HCM group had longer mean AT (60.1 ms vs. 52.2 ms, p < 0.001), activation dispersion (55.2 ms vs. 48.6 ms, p = 0.026), and mean ARI (227 ms vs. 217 ms, p = 0.016) than structurally normal heart controls. HCM ventricular arrhythmia survivors could be differentiated from HCM patients without a personal history of life-threatening arrhythmia by longer mean AT (63.2 ms vs. 57.4 ms, p = 0.007), steeper activation gradients (0.45 ms/mm vs. 0.36 ms/mm, p = 0.011), and longer mean ARI (234.0 ms vs. 221.4 ms, p = 0.026). A logistic regression model including whole heart mean activation time and activation recovery interval could identify ventricular arrhythmia survivors from the HCM cohort, producing a C statistic of 0.76 (95% confidence interval 0.72-0.81), with an optimal sensitivity of 78.6% and a specificity of 79.8%. Discussion: The HCM epicardial electrotype is characterized by delayed, dispersed conduction and prolonged, dispersed activation-recovery intervals. Combination of electrophysiologic measures with logistic regression can improve differentiation over single variables. Future studies could test such models prospectively for risk stratification of sudden death due to HCM.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy
    Choi, J., I
    Jeong, J. H.
    Kook, H. D.
    Lee, H. S.
    Choi, Y. Y.
    Kim, S. R.
    Cho, D. H.
    Kim, Y. G.
    Kim, M. N.
    Shim, J.
    Park, S. M.
    Kim, Y. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] A Genetic Link to Atrial Substrate in Hypertrophic Cardiomyopathy?
    Dinshaw, Leon
    Meyer, Christian
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (07) : 1392 - 1394
  • [43] CT characterization of myocardial substrate in hypertrophic cardiomyopathy
    Gore, Rosco
    Abraham, Theodore
    George, Richard T.
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2014, 8 (02) : 166 - 169
  • [44] Nuclear cardiac imaging in hypertrophic cardiomyopathy
    Shirani, Jamshid
    Dilsizian, Vasken
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (01) : 123 - 134
  • [45] Nuclear cardiac imaging in hypertrophic cardiomyopathy
    Jamshid Shirani
    Vasken Dilsizian
    Journal of Nuclear Cardiology, 2011, 18 : 123 - 134
  • [46] Multimodality imaging in apical hypertrophic cardiomyopathy
    Parisi, Rosario
    Mirabella, Francesca
    Secco, Gioel Gabrio
    Fattori, Rossella
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (09): : 916 - 923
  • [47] Myocardial Perfusion Imaging in Hypertrophic Cardiomyopathy
    Dilsizian, Vasken
    Panza, Julio A.
    Bonow, Robert O.
    JACC-CARDIOVASCULAR IMAGING, 2010, 3 (10) : 1078 - 1080
  • [48] Magnetic Resonance Imaging of Hypertrophic Cardiomyopathy
    Tsang, K. H.
    Chan, W. S. W.
    Shiu, C. K.
    Lee, J. C. Y.
    Chan, M. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2018, 21 (04): : 274 - 279
  • [49] Scanning the Imaging Horizon for Hypertrophic Cardiomyopathy
    Crean, Andrew M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2024, 40 (05) : 899 - 906
  • [50] SPECT imaging of apical hypertrophic cardiomyopathy
    Chu, WW
    Wallhaus, TR
    Bianco, JA
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (11) : 785 - 787